当前位置: X-MOL 学术Eur. Polym. J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Chitosan biopolymer, its derivatives and potential applications in nano-therapeutics: A comprehensive review
European Polymer Journal ( IF 6 ) Pub Date : 2021-09-13 , DOI: 10.1016/j.eurpolymj.2021.110767
Mahwash Mukhtar 1 , Eszter Fényes 1 , Csilla Bartos 1 , Mahira Zeeshan 2 , Rita Ambrus 1
Affiliation  

Chitosan (CS) is a natural biopolymer used frequently in drug delivery because of its biodegradability and biocompatibility. Several derivatives of CS have also been synthesized to improve the mucoadhesion and solubility of the nascent CS. The nano and micro particles are reported to have enhanced drug bioavailability, solubility and permeation. Recently, there is an advancement in the active targeted drug and gene delivery using CS because of its tunable surface modifications. This review focuses on CS and its chemically modified structures along with their different nanostructures with examples from the most exploited routes of administration. Herein, the functionalization of CS nanoparticles has also been enlisted along with the use of CS in the immunotherapy as vaccine carriers. Beside, few patents, ongoing clinical trials and already marketed CS-based products are also enlisted.



中文翻译:

壳聚糖生物聚合物、其衍生物及其在纳米治疗中的潜在应用:综合综述

壳聚糖 (CS) 是一种天然生物聚合物,因其可生物降解性和生物相容性而经常用于药物递送。还合成了几种 CS 衍生物以改善新生 CS 的粘膜粘附和溶解度。据报道,纳米和微米颗粒具有增强的药物生物利用度、溶解度和渗透性。最近,由于其可调的表面修饰,在使用 CS 的主动靶向药物和基因递送方面取得了进展。本综述重点介绍 CS 及其化学改性结构及其不同的纳米结构,并举例说明了最常用的给药途径。在此,CS 纳米粒子的功能化也与 CS 在免疫治疗中作为疫苗载体的使用一起被纳入。此外,很少有专利,

更新日期:2021-09-21
down
wechat
bug